-
Something wrong with this record ?
Clinical and molecular-genetic markers of ADHD in children
I Drtilkova, O Sery, P Theiner, A Uhrova, M Zackova, B Balastikova, V Znojil
Language English Country Sweden
Grant support
NR9298
MZ0
CEP Register
Digital library NLK
Full text - Část
Source
- MeSH
- Biomarkers MeSH
- Discrimination, Psychological physiology MeSH
- Child MeSH
- Phenotype MeSH
- Financing, Organized MeSH
- Genetic Markers MeSH
- Genotype MeSH
- Attention Deficit Disorder with Hyperactivity epidemiology genetics metabolism MeSH
- Humans MeSH
- Methylphenidate therapeutic use MeSH
- Adolescent MeSH
- Neuropsychological Tests MeSH
- Polymorphism, Genetic genetics MeSH
- Attention physiology drug effects MeSH
- Psychiatric Status Rating Scales MeSH
- Psychomotor Performance physiology drug effects MeSH
- Receptors, Dopamine D2 genetics MeSH
- Central Nervous System Stimulants therapeutic use MeSH
- Form Perception physiology MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Geographicals
- Czech Republic MeSH
OBJECTIVES: The objective was to make a contribution to deepening the knowledge of the etiopathogenesis of ADHD. DESIGN: In an association study design, an analysis of polymorphisms of selected genes was conducted in 119 hyperkinetic boys and a control group of boys, aged 7-13. Furthermore several psychologically determined subgroups were identified. A connection between psychological functions (endophenotypes) and genes were looked for. RESULTS: There was a statistically significant difference found in allelic and genotype frequencies of the TaqI A polymorphism of the DRD2 gene. The frequency of the allele A1 in hyperkinetic boys and the control subjects was 0.26 and 0.15, respectively (p<0.003). A statistically significant occurrence of atypical genotypes (8/10, 7/10 and 10/11) of the DAT1 gene was also found in hyperkinetic boys and a connection between the M235 polymorphism of the angiotensinogene gene and the positive family history of psychiatric illness was found in probands (p=0.031). Significant correlations between the results of some neuropsychological tests and genes for neuro-/immunomodulators (IL-6, TNF-alpha) and the gene for the brain-derived neurotrophic factor (BDNF) were found. CONCLUSION: The study showed a statistically significant prevalence of A1 allele of the DRD gene in the hyperkinetic group. We also found a significantly higher incidence of atypical DAT genotypes in the hyperkinetic group. Furthermore we found significant connections with particular gene polymorphisms which may hypothetically represent a neurodevelopmental risk factor in the etiopathogenesis of the disorder (IL-2, IL-6, TNF-alpha, BDNF). We further found a connection of the M235 polymorphism of the AGT (angiotensinogene) gene to positive family history of psychiatric illness (p=0.031). As for cognitive characteristics, we identified three subtypes with different cognitive performance profiles. This finding shows interindividual variability of cognitive style in the group of hyperkinetic boys.
- 000
- 02306naa 2200565 a 4500
- 001
- bmc11003996
- 003
- CZ-PrNML
- 005
- 20140307115659.0
- 008
- 110303s2008 sw e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Drtílková, Ivana, $d 1944- $7 nlk20040156087
- 245 10
- $a Clinical and molecular-genetic markers of ADHD in children / $c I Drtilkova, O Sery, P Theiner, A Uhrova, M Zackova, B Balastikova, V Znojil
- 314 __
- $a Department of Psychiatry, Faculty Hospital and Masaryk University Brno, Czech Republic. idrtilkova@fnbrno.cz
- 520 9_
- $a OBJECTIVES: The objective was to make a contribution to deepening the knowledge of the etiopathogenesis of ADHD. DESIGN: In an association study design, an analysis of polymorphisms of selected genes was conducted in 119 hyperkinetic boys and a control group of boys, aged 7-13. Furthermore several psychologically determined subgroups were identified. A connection between psychological functions (endophenotypes) and genes were looked for. RESULTS: There was a statistically significant difference found in allelic and genotype frequencies of the TaqI A polymorphism of the DRD2 gene. The frequency of the allele A1 in hyperkinetic boys and the control subjects was 0.26 and 0.15, respectively (p<0.003). A statistically significant occurrence of atypical genotypes (8/10, 7/10 and 10/11) of the DAT1 gene was also found in hyperkinetic boys and a connection between the M235 polymorphism of the angiotensinogene gene and the positive family history of psychiatric illness was found in probands (p=0.031). Significant correlations between the results of some neuropsychological tests and genes for neuro-/immunomodulators (IL-6, TNF-alpha) and the gene for the brain-derived neurotrophic factor (BDNF) were found. CONCLUSION: The study showed a statistically significant prevalence of A1 allele of the DRD gene in the hyperkinetic group. We also found a significantly higher incidence of atypical DAT genotypes in the hyperkinetic group. Furthermore we found significant connections with particular gene polymorphisms which may hypothetically represent a neurodevelopmental risk factor in the etiopathogenesis of the disorder (IL-2, IL-6, TNF-alpha, BDNF). We further found a connection of the M235 polymorphism of the AGT (angiotensinogene) gene to positive family history of psychiatric illness (p=0.031). As for cognitive characteristics, we identified three subtypes with different cognitive performance profiles. This finding shows interindividual variability of cognitive style in the group of hyperkinetic boys.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a pozornost $x fyziologie $x účinky léků $7 D001288
- 650 _2
- $a hyperkinetická porucha $x epidemiologie $x genetika $x metabolismus $7 D001289
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a stimulanty centrálního nervového systému $x terapeutické užití $7 D000697
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a diskriminace (psychologie) $x fyziologie $7 D004192
- 650 _2
- $a vnímání tvaru $x fyziologie $7 D005556
- 650 _2
- $a genetické markery $7 D005819
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methylfenidát $x terapeutické užití $7 D008774
- 650 _2
- $a neuropsychologické testy $7 D009483
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a polymorfismus genetický $x genetika $7 D011110
- 650 _2
- $a psychiatrické posuzovací škály $7 D011569
- 650 _2
- $a psychomotorický výkon $x fyziologie $x účinky léků $7 D011597
- 650 _2
- $a receptory dopaminu D2 $x genetika $7 D017448
- 650 _2
- $a financování organizované $7 D005381
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 700 1_
- $a Šerý, Omar, $d 1972- $7 xx0060835
- 700 1_
- $a Theiner, Pavel $7 xx0053973
- 700 1_
- $a Fiľová, Alena, $d 1980- $7 mzk2007377414
- 700 1_
- $a Žáčková, Markéta $7 xx0088516
- 700 1_
- $a Balaštíková, Blanka $7 xx0061861
- 700 1_
- $a Znojil, Vladimír, $d 1941-2008 $7 ola2003204904
- 773 0_
- $t Neuroendocrinology Letters $w MED00168352 $g Roč. 29, č. 3 (2008), s. 320-327 $x 0172-780X
- 910 __
- $a ABA008 $b x $y 1 $z 0
- 990 __
- $a 20110413122230 $b ABA008
- 991 __
- $a 20140307115704 $b ABA008
- 999 __
- $a ok $b bmc $g 831336 $s 696021
- BAS __
- $a 3
- BMC __
- $a 2008 $b 29 $c 3 $d 320-327 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- GRA __
- $a NR9298 $p MZ0
- LZP __
- $a 2011-3B/ipme